A study to find a suitable dose of BI 765883 and to test whether it helps people with advanced pancreatic cancer when taken alone or together with chemotherapy

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-508998-85-00

Acronym

1505-0001

Enrollment

Registered

2024-08-05

Start date

2025-01-28

Completion date

2025-05-22

Last updated

2024-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic pancreatic ductal adenocarcinoma (mPDAC)

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, France, Germany, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026